Table 3.
Second Malignancies
| Primary Disease | Type of Second Cancer | Derivation | Outcomes | |
|---|---|---|---|---|
| AML | MDS/MPD | Donor | Fatal | |
| Hodgkin lymphoma | PTLD | Donor | Fatal | |
| Non-Hodgkin lymphoma (NHL) | MDS/MPD | Donor | Fatal | |
| Hodgkin lymphoma | PTLD | Unknown | Fatal | |
| CLL | PTLD | Donor | Fatal | |
| MDS | PTLD | Donor | Fatal | |
| AML | PTLD | Donor | Fatal | |
| MDS | PTLD | Donor | Alive, in CR | |
| NHL | PTLD | Donor | Fatal | |
| Hodgkin lymphoma | PTLD | Donor | Fatal | |
| AML | PTLD | Donor | Fatal | |
| AML | PTLD | Donor | Alive, in CR | |
| NHL | PTLD | Donor | Fatal | |
| NHL | PTLD | Donor | Fatal | |
| MDS | PTLD | Donor | Fatal | |
| Aplastic Anemia | PTLD | Donor | Alive, in CR | |
| Aplastic Anemia | PTLD | Donor | Alive, in CR | |
| CML | PTLD | Unknown | Alive, in CR | |